Constellium (CSTM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Aug, 2026Executive summary
Achieved record quarterly and half-year Adjusted EBITDA, with Q2 2026 Adjusted EBITDA at $439 million, up 201% year-over-year, and strong performance across all segments, driven by operational focus, cost control, and improved market dynamics, especially in aerospace, transportation, and recycling.
Revenue rose 31% year-over-year in Q2 2026 to $2.7 billion, with net income of $148 million, up from $36 million in Q2 2025.
Free Cash Flow was $90 million in Q2 and $95 million for H1 2026, with $20 million returned to shareholders via share repurchases in Q2.
Safety performance improved, with a recordable case rate of 1.3 per million hours YTD, down from 1.9 in 2025.
Maintains optimism for the remainder of 2026, focusing on strategy execution, operational performance, cost control, and shareholder value.
Financial highlights
Q2 2026 Adjusted EBITDA was $439 million, including a $129 million positive non-cash metal price lag; H1 2026 Adjusted EBITDA was $798 million, up 140% year-over-year.
Net income for Q2 2026 was $148 million; basic EPS for Q2 2026 was $1.07, up from $0.25 in Q2 2025.
Free Cash Flow was $90 million in Q2 and $95 million for H1 2026.
Leverage ratio at June 30, 2026 was 1.8x, within the target range of 1.5–2.5x.
Liquidity at June 30, 2026 was $1,058 million, including $163 million in cash.
Outlook and guidance
Raised 2026 guidance: Adjusted EBITDA (excluding metal price lag) targeted at $980 million–$1.02 billion; Free Cash Flow expected to exceed $300 million.
CapEx guidance unchanged at $330 million, including $100 million for return-seeking projects.
2028 targets now expected to be achieved two years ahead of schedule.
Guidance assumes stable macroeconomic conditions and continuation of current demand trends.
Focus remains on operational execution, cost control, and capital discipline amid ongoing macroeconomic and geopolitical volatility.
Latest events from Constellium
- Revenue up 5% and net income up 73% in Q1 2025, with guidance reaffirmed.CSTM
Q1 20258 Jul 2026 - Q2 2024: Net income rose, cash flow strong, Swiss flooding paused guidance, 2025 target reaffirmed.CSTM
Q2 20248 Jul 2026 - Record Adjusted EBITDA and net income, with raised 2026 outlook and strong liquidity.CSTM
Q1 202629 Apr 2026 - Director appointments, executive pay, and share repurchase authorizations recommended for approval.CSTM
Proxy filing10 Apr 2026 - Shareholders will vote on director appointments, executive pay, financials, and share repurchases.CSTM
Proxy filing10 Apr 2026 - Shareholders to vote on director appointments, executive pay, and share repurchase plans after a strong 2025.CSTM
Proxy filing30 Mar 2026 - Record 2025 results, strong cash flow, reduced leverage, and Vision 2028 launched.CSTM
Q4 202518 Feb 2026 - Q3 2024 results were hit by lower volumes, flood losses, and weak demand across key markets.CSTM
Q3 202419 Jan 2026 - 2024 saw lower results from disruptions, but 2025–2028 targets reflect recovery and growth.CSTM
Q4 20246 Jan 2026